Antiretroviral therapy coverage in France
France: Antiretroviral therapy coverage was 91.0% in 2022. ▲ Rising
Antiretroviral therapy coverage in France, 2000–2022
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
In 2022, antiretroviral therapy coverage in France stood at 91.0%. That is the highest value across all 23 years on record.
That represents a change of up 1.1% on the previous year and up 5.8% over ten years.
Over the whole period, antiretroviral therapy coverage in France peaked at 91.0% in 2022 and was at its lowest, 76.0%, in 2000.
France ranks 17th of 143 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 23 years of available data.
Antiretroviral therapy coverage in France, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 76.0% | — |
| 2001 | 77.0% | +1.3% |
| 2002 | 78.0% | +1.3% |
| 2003 | 79.0% | +1.3% |
| 2004 | 79.0% | +0.0% |
| 2005 | 80.0% | +1.3% |
| 2006 | 81.0% | +1.2% |
| 2007 | 82.0% | +1.2% |
| 2008 | 83.0% | +1.2% |
| 2009 | 84.0% | +1.2% |
| 2010 | 85.0% | +1.2% |
| 2011 | 86.0% | +1.2% |
| 2012 | 86.0% | +0.0% |
| 2013 | 87.0% | +1.2% |
| 2014 | 88.0% | +1.1% |
| 2015 | 90.0% | +2.3% |
| 2016 | 90.0% | +0.0% |
| 2017 | 90.0% | +0.0% |
| 2018 | 89.0% | -1.1% |
| 2019 | 89.0% | +0.0% |
| 2020 | 89.0% | +0.0% |
| 2021 | 90.0% | +1.1% |
| 2022 | 91.0% | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 79.9% | 76.0% | 84.0% | 10 |
| 2010s | 88.0% | 85.0% | 90.0% | 10 |
| 2020s | 90.0% | 89.0% | 91.0% | 3 |
Countries ranked near France
More health data for France
- Un projection of annual infant deaths, annual growth rate -1.31 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0689 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,016 deaths per 1,000 people (2090)
- Number of infants who die before age 1 603 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate -0.7875 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0244 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8291 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in France?
- Antiretroviral therapy coverage in France was 91.0% in 2022, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in France?
- The highest recorded value was 91.0% in 2022.
- What is the lowest antiretroviral therapy coverage recorded in France?
- The lowest recorded value was 76.0% in 2000.
- How does France rank for antiretroviral therapy coverage?
- France ranks 17th out of 143 countries with data for 2022.
- Is antiretroviral therapy coverage rising or falling in France?
- Over the last ten years it is up 5.8%. The long-run trend across the full record is rising.
- Where does this France data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.